3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
8
Other hematologic neoplasm
4
Thoracic
1
Plasma cell
1
Other solid neoplasm
1
Myeloid
1
Genitourinary
1
Gastrointestinal
1
Dermatologic
1
CNS
1
Conditions
Melanoma
1103
Carcinoma, Non-Small-Cell Lung
281
Neoplasms
199
Keratosis, Actinic
181
Carcinoma, Renal Cell
162
Skin Neoplasms
143
Colorectal Neoplasms
142
Neoplasm Metastasis
140
Squamous Cell Carcinoma of Head and Neck
134
Breast Neoplasms
118
Ovarian Neoplasms
114
Carcinoma, Basal Cell
97
Stomach Neoplasms
94
Pancreatic Neoplasms
93
Lung Neoplasms
91
Head and Neck Neoplasms
90
Lymphoma, T-Cell, Cutaneous
88
Uterine Cervical Neoplasms
75
Triple Negative Breast Neoplasms
74
Sarcoma
68
Carcinoma, Hepatocellular
67
Prostatic Neoplasms
65
Uveal Melanoma
64
Carcinoma, Merkel Cell
64
Urinary Bladder Neoplasms
63
Esophageal Neoplasms
61
Carcinoma, Transitional Cell
57
Lymphoma
55
Endometrial Neoplasms
55
Small Cell Lung Carcinoma
52
Interventions
bemcentinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
INDUSTRY
×
COVID-19
×
Dermatologic
×
Clear all
NCT06469138
2025-01-29
8479217
BerGenBio ASA
Phase 1
Completed
6 enrolled
17 charts